Cognex Corp (NASDAQ: CGNX) kicked off on Friday, down -12.43% from the previous trading day, before settling in for the closing price of $46.57. Over the past 52 weeks, CGNX has traded in a range of $22.67-$47.52.
Annual sales at Technology sector company slipped by -11.96% over the past five years. While this was happening, its average annual earnings per share was recorded 48.35%. With a float of $167.43 million, this company’s outstanding shares have now reached $167.90 million.
Cognex Corp (CGNX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Scientific & Technical Instruments Industry. The insider ownership of Cognex Corp is 0.28%, while institutional ownership is 97.67%. The most recent insider transaction that took place on Sep 05 ’25, was worth 90,090. In this transaction EVP, Employee Services of this company sold 2,002 shares at a rate of $45.00, taking the stock ownership to the 8,582 shares. Before that another transaction happened on Sep 08 ’25, when Company’s EVP, Employee Services sold 2,000 for $45.03, making the entire transaction worth $90,060. This insider now owns 6,582 shares in total.
Cognex Corp (CGNX) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported 0.2 earnings per share (EPS), higher than consensus estimate (set at 0.19) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.35% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.82% during the next five years compared to -11.96% drop over the previous five years of trading.
Cognex Corp (NASDAQ: CGNX) Trading Performance Indicators
Take a look at Cognex Corp’s (CGNX) current performance indicators. Last quarter, stock had a quick ratio of 2.45. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.37. Likewise, its price to free cash flow for the trailing twelve months is 38.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.71, a number that is poised to hit 0.29 in the next quarter and is forecasted to reach 1.16 in one year’s time.
